Here are five things to know:
1. The $30 million grant will support researchers better understand the safety and effectiveness of three blood-thinning drugs used to prevent potentially fatal blood clots in patients undergoing hip and knee replacements.
2. The study will involve major professional societies and associations, payers, national advocacy organizations and other important patient and stakeholder groups in research design and implementation.
3. The project has been approved by the PCORI board pending the completion of a business and programmatic review by PCORI staff and issuance of formal award contracts.
4. The PCORI has awarded or approved almost $1.08 billion for research projects and other initiative aimed at helping patients and those who care for them to make more informed healthcare choices.
5. The PCORI is working to develop studies that operate faster and more efficiently than traditional research approaches.
More articles on orthopedics:
3 facts on Lincoln Orthopaedic Center’s new orthopedic surgeon Dr. Jason Weber
Dr. Gregory Mallo joins Orthopedic Associates of Long Island — 6 notes
Orthopedic surgeon to know: Dr. Michael G. Dulske of Capital Orthopaedic & Sports Medicine Center
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
